M3 Clinician was validated in a study performed at the University of North Carolina,
and published in the Annals of Family Medicine. It was shown to effectively screen
for Depression, Bipolar Disorder and a range of Anxiety Disorders, including PTSD,
using a single 27-item, patient-rated, evidence-based screen.
Clinical Decision Support at the Point of Care
M3 Clinician provides an individualized patient assessment geared toward early detection,co-morbid
illness, and identifying people in distress irrespective of their particular diagnosis.
Meanwhile, its dimensional subscores help to place patients on a clinical map, leading
the clinician toward the appropriate diagnosis. M3 Clinician facilitates longitudinal
monitoring and communication among the care team members in a medical home environment.
M3 Clinician enables providers to quickly and accurately screen for a wide range
of mood and anxiety disorders. M3 helps find unidentified cases, avoid mistreatment
and allows you to monitor patients over time. Clinicians can feel assured that they
are administering an evidence-based personalized treatment plans for each of their
As many as 70% of all primary care visits are precipitated by underlying mental
health issues. Being able to avoid the complications and confusion that such symptoms
often bring is naturally a valuable asset. By promoting early detection, M3 Clinician
can forestall disease progression, and prevent unnecessary ED visits, and hospitalizations.